A Study of CRD3874-SI in People With Leukemia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid leukemia (AML).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Zdiagnozowana ostra białaczka szpikowa, która nie odpowiada na leczenie lub wróciła po poprzedniej terapii
- •Wiek co najmniej 18 lat
- •Waga co najmniej 40 kg
- •Ogólny stan zdrowia pozwalający na udział w badaniu (ocena ECOG 0-2)
- •Jeśli pacjent ma HIV, musi przyjmować leki przeciwwirusowe z niewykrywalnym wirusem w ciągu 6 miesięcy
- •Jeśli pacjent ma zapalenie wątroby typu B, wirus musi być niewykrywalny przy leczeniu
- •Jeśli pacjent miał zapalenie wątroby typu C, musi być wyleczony lub mieć niewykrywalny wirus
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 22, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (7)
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)
Basking Ridge, United States
Memorial Sloan Kettering Monmouth (All protocol activities)
Middletown, United States
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, United States
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities)
Commack, United States
Memorial Sloan Kettering Westchester (All protocol activities)
Harrison, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, United States
Memorial Sloan Kettering Nassau (All Protocol Activities)
Rockville Centre, United States
Trial contact
Eytan Stein, MD
Aaron Goldberg, MD, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/23/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.